EMBC
Embecta Corp.
+0.05 (+1.07%)5.19USD170K成交股數294M市值3.5本益比(近四季)0.3股價營收比-8.1%營收年增(近四季)2026-11-25下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 9 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 272M-8% | 222M-14% | 261M-0% | 264M-3% | 296M+3% | 259M-7% | 262M-7% | 273M-5% | 287M | 277M | 282M | 286M |
| 營業成本 | 118M | 94.0M | 99.5M | 106M | 98.4M | 94.9M | 105M | 82.4M | 102M | 91.4M | 100M | 96.6M |
| 毛利 | 153M-22% | 128M-22% | 162M+3% | 159M-17% | 197M+6% | 164M-12% | 157M-14% | 190M+0% | 185M | 186M | 182M | 190M |
| 毛利率 | 56.4% | 57.6% | 61.9% | 60.0% | 66.7% | 63.4% | 60.0% | 69.8% | 64.6% | 67.0% | 64.5% | 66.2% |
| 研發費用 | 5.6M | 5.4M | 4.6M | 4.6M | 4.4M | 8.0M | 20.3M | 20.4M | 18.4M | 20.2M | 23.6M | 22.6M |
| 銷售管理費用 | 78.6M | 76.2M | 77.6M | 86.9M | 84.4M | 79.6M | 81.1M | 85.7M | 92.3M | 90.3M | 95.7M | 87.6M |
| 營業利益 | 48.7M-48% | 35.0M-44% | 83.3M+190% | 56.5M+1% | 94.0M+140% | 62.9M+38% | 28.7M+11% | 55.9M+9% | 39.2M | 45.5M | 25.8M | 51.3M |
| 營業利益率 | 17.9% | 15.8% | 31.9% | 21.4% | 31.8% | 24.3% | 11.0% | 20.5% | 13.6% | 16.4% | 9.2% | 17.9% |
| 稅後淨利 | 21.1M-54% | −4.1M-117% | 44.1M | 26.4M+80% | 45.5M+57% | 23.5M+17% | 0-100% | 14.7M-3% | 28.9M | 20.1M | 6.0M | 15.2M |
| 淨利率 | 7.8% | -1.8% | 16.9% | 10.0% | 15.4% | 9.1% | 0.0% | 5.4% | 10.1% | 7.2% | 2.1% | 5.3% |
| 稀釋 EPS | 0.36-54% | -0.07-118% | 0.74 | 0.44+76% | 0.78+56% | 0.40+14% | 0.00-100% | 0.25-4% | 0.50 | 0.35 | 0.11 | 0.26 |
| 稀釋股數 | 58.5M | 59.3M | 59.3M | 58.9M | 58.5M | 58.5M | 58.6M | 57.8M | 57.8M | 57.6M | 57.8M | 57.6M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 215M | 185M | 201M | 226M | 231M | 209M | 210M | 275M | 300M | 299M | 326M | 317M |
| 應收帳款 | 182M | 147M | 159M | 146M | 183M | 186M | 181M | 172M | 124M | 96.1M | 16.7M | 21.1M |
| 存貨 | 214M | 193M | 182M | 179M | 190M | 169M | 169M | 186M | 153M | 149M | 152M | 170M |
| 總資產 | 1.3B | 1.0B | 1.1B | 1.1B | 1.2B | 1.1B | 1.1B | 1.3B | 1.2B | 1.2B | 1.2B | 1.3B |
| 有息負債 | 1.3B | 1.3B | 1.4B | 1.4B | 1.5B | 1.5B | 1.5B | 1.6B | 1.6B | 1.6B | 1.6B | 1.6B |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | −613M | −626M | −613M | −651M | −670M | −736M | −769M | −764M | −770M | −794M | −822M | −809M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | −1.1B | −1.1B | −1.2B | −1.2B | −1.2B | −1.3B | −1.3B | −1.3B | −1.3B | −1.3B | −1.3B | −1.3B |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | 17.2M-425% | – | – | – | −5.3M | – | – | −13.1M | – | – |
| 資本支出 | – | – | 600K | – | – | – | 1.5M | – | – | 2.7M | – | – |
| 自由現金流 | – | – | 16.6M-344% | – | – | – | −6.8M | – | – | −15.8M | – | – |
| 折舊攤銷 | – | – | 10.3M | – | – | – | 9.4M | – | – | 8.8M | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | 8.9M | – | – | – | 8.8M | – | – | 8.6M | – | – |
| 自由現金流率 | – | – | 6.4% | – | – | – | -2.6% | – | – | -5.7% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 1.1B
| 美國 | 579M | 53.6% | -4.6% |
|---|---|---|---|
| 美國以外 | 501M | 46.4% | -2.8% |
產品／服務2025 年度 · 943M
| Pen Needles | 784M | 83.2% | -7.1% |
|---|---|---|---|
| Syringes | 125M | 13.2% | -1.3% |
| Manufacturing Facility | 19.9M | 2.1% | +55.5% |
| Product And Service Other | 14.0M | 1.5% | +35.9% |
| Safety 小計 | 138M | 14.6% | +6.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 1.1B | -3.8% | 95.4M | 8.8% | 1.62 | 182M |
| FY2024 | 1.1B | +0.2% | 78.3M | 7.0% | 1.34 | 19.9M |
| FY2023 | 1.1B | -0.8% | 70.4M | 6.3% | 1.22 | 41.2M |
| FY2022 | 1.1B | -3.1% | 224M | 19.8% | 3.89 | 389M |
| FY2021 | 1.2B | +7.4% | 415M | 35.6% | 7.28 | 420M |
| FY2020 | 1.1B | – | 428M | 39.4% | 7.50 | 457M |